Methodology of Clinical Trials Aimed at Assessing Interventions for Cutaneous Leishmaniasis
Open Access
- 21 March 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 7 (3) , e2130
Abstract
The current evidence-base for recommendations on the treatment of cutaneous leishmaniasis (CL) is generally weak. Systematic reviews have pointed to a general lack of standardization of methods for the conduct and analysis of clinical trials of CL, compounded with poor overall quality of several trials. For CL, there is a specific need for methodologies which can be applied generally, while allowing the flexibility needed to cover the diverse forms of the disease. This paper intends to provide clinical investigators with guidance for the design, conduct, analysis and report of clinical trials of treatments for CL, including the definition of measurable, reproducible and clinically-meaningful outcomes. Having unified criteria will help strengthen evidence, optimize investments, and enhance the capacity for high-quality trials. The limited resources available for CL have to be concentrated in clinical studies of excellence that meet international quality standards. Solid evidence is needed to decide how to treat conditions. In the case of cutaneous leishmaniasis, the diversity of clinical conditions, combined with the heterogeneity and weaknesses of the methodologies used in clinical trials, make it difficult to derive robust conclusions as to which treatments should be used. There also other imperatives - ethical (not exposing patients to treatments that cannot be assessed adequately) and financial (optimize use of limited resources for a neglected condition). This paper is meant to provide clinical investigators with guidance for the design, conduct, analysis and report of clinical trials to assess the efficacy and safety of treatments of this condition.Keywords
This publication has 48 references indexed in Scilit:
- Designing and Reporting Clinical Trials on Treatments for Cutaneous LeishmaniasisClinical Infectious Diseases, 2010
- Clinical and Demographic Stratification of Test Performance: A Pooled Analysis of Five Laboratory Diagnostic Methods for American Cutaneous LeishmaniasisThe American Journal of Tropical Medicine and Hygiene, 2010
- WR279,396, a Third Generation Aminoglycoside Ointment for the Treatment of Leishmania major Cutaneous Leishmaniasis: A Phase 2, Randomized, Double Blind, Placebo Controlled StudyPLOS Neglected Tropical Diseases, 2009
- Pharmacokinetics of Antimony in Children Treated for Leishmaniasis with Meglumine AntimoniateThe Journal of Infectious Diseases, 2007
- Reporting of Noninferiority and Equivalence Randomized TrialsJAMA, 2006
- Therapeutic equivalence: fallacies and falsificationStatistics in Medicine, 2003
- Statistical Methods for Comparison to Placebo in Active-Control TrialsDrug Information Journal, 2001
- Consensus and Controversy in Pharmaceutical StatisticsJournal of the Royal Statistical Society: Series D (The Statistician), 2000
- Detecting alcoholism. The CAGE questionnaireJAMA, 1984
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958